New possibilities for the future
Progenicyte Japan is a venture company aiming at the commercialization of a small molecule compound to increase endogenous stem cells, which was developed by Dr. Kiminobu Sugaya and his research group. Dr. Sugaya is a professor and head of neuroscience at the University of Central Florida, College of Medicine, located in Florida, USA. In our company, peoples with a variety of expertise in different fields are working hard together to reach our goal, which is to bring innovative technologies from the bench to the world.
Company name: PROGENICYTE JAPAN CO., LTD.
Founding Date : January 24, 2020
Capital : 7.5 million yen
Address : Kobe International Conference Center S606
6-9-1 Minatojima Nakamachi, Chuo-ward
Kobe-city, Hyogo 650-0046, Japan
URL : https://www.progenicyte.com
Co Representative Director and Chair
Kiminobu Sugaya, PhD
and Head of Neuroscience, University of
Visiting Professor, Clinical Research, Innovation and Education Center,
Tohoku University Hospital
Honorary Professor, The University of United Arab Emirates, Al-Ain, UEA
Honorary Professor, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología AIP, Panama
Co Representative Director and CEO
investor and consultant for new business development. Experience in working for
IT Venture International Marketing PL and a major business company New Business
Development Department MG.
She met Sugaya in the United States, Florida, believed in the potential of his technologies, and developing them together in Japan.
United States Marine Corps
Former founder and CEO, Con-Air Industries
Mohtashem Samsam, MD, PhD
Advent Health, Research Institute, Orlando, Florida
David Francis Leon
The Florida Bar
Nelson Mullins Broad and Cassel